Related references
Note: Only part of the references are listed.Renal function in newly diagnosed multiple myeloma - A demographic study of 1353 patients
Lene Meldgaard Knudsen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Reversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myeloma
Heinz Ludwig et al.
HAEMATOLOGICA (2007)
Community experience with bortezomib in patients with multiple myeloma
Adedayo A. Onitilo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study
Asher A. Chanan-Khan et al.
BLOOD (2007)
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma:: results of a multicenter phase 1/2 study
Maria-Victoria Mateos et al.
BLOOD (2006)
Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function
Andrea Nozza et al.
CLINICAL THERAPEUTICS (2006)
Bortezomib and dexamethasone in previously untreated multiple myeloma associated with renal failure and reversal of renal failure
Ashok Kumar Malani et al.
ACTA HAEMATOLOGICA (2006)
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma
HE Oakervee et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies
RZ Orlowski et al.
BLOOD (2005)
Bortezornib in recurrent and/or refractory multiple myeloma - Initial clinical experience in patients with impaired renal function
S Jagannath et al.
CANCER (2005)
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma
S Jagannath et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
A phase 2 study of bortezomib in relapsed, refractory myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Review of 1027 patients with newly diagnosed multiple myeloma
RA Kyle et al.
MAYO CLINIC PROCEEDINGS (2003)
Renal failure in multiple myeloma: reversibility and impact on the prognosis
LM Knudsen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2000)
Renal involvement in multiple myeloma: A 10-year study
V Sakhuja et al.
RENAL FAILURE (2000)
Share Paper
